These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

509 related items for PubMed ID: 16246182

  • 1. Recovery of gastric function after Helicobacter pylori eradication in subjects with body atrophic gastritis: prospective 4-year study.
    Di Mario F, Moussa AM, Dal Bò N, Caruana P, Pilotto A, Cavallaro LG, Cavestro GM, Iori V, Merli R, Franzé A, Rugge M.
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1661-6. PubMed ID: 16246182
    [Abstract] [Full Text] [Related]

  • 2. Histological and functional recovery in patients with multifocal atrophic gastritis after eradication of Helicobacter pylori infection.
    Savarino V, Mela GS, Zentilin P, Lapertosa G, Bisso G, Mele MR, Pivari M, Mansi C, Vigneri S, Celle G.
    Ital J Gastroenterol Hepatol; 1999 Nov; 31(1):4-8. PubMed ID: 10091096
    [Abstract] [Full Text] [Related]

  • 3. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
    Ohkusa T, Miwa H, Nomura T, Asaoka D, Kurosawa A, Sakamoto N, Abe S, Hojo M, Terai T, Ogihara T, Sato N.
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
    [Abstract] [Full Text] [Related]

  • 4. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
    Pimanov SI, Makarenko EV, Voropaeva AV, Matveenko ME, Voropaev EV.
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
    [Abstract] [Full Text] [Related]

  • 5. Long-term strict monitoring of plasma ghrelin and other serological markers of gastric diseases after Helicobacter pylori eradication.
    Masaoka T, Suzuki H, Imaeda H, Hosoda H, Ohara T, Morishita T, Ishii H, Kangawa K, Hibi T.
    Hepatogastroenterology; 2005 Nov; 52(61):1-4. PubMed ID: 15782980
    [Abstract] [Full Text] [Related]

  • 6. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
    Walecka-Kapica E, Knopik-Dabrowicz A, Klupińska G, Chojnacki J.
    Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
    [Abstract] [Full Text] [Related]

  • 7. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study.
    Sipponen P, Ranta P, Helske T, Kääriäinen I, Mäki T, Linnala A, Suovaniemi O, Alanko A, Härkönen M.
    Scand J Gastroenterol; 2002 Jul; 37(7):785-91. PubMed ID: 12190091
    [Abstract] [Full Text] [Related]

  • 8. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
    Bölükbaş C, Bölükbaş FF, Ovünç O, Kiliç G, Dalay R, Güven H, Uras F, Yardimci TK, Sökmen MH, Agan AF, Pişkinpaşa N.
    Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
    [Abstract] [Full Text] [Related]

  • 9. Helicobacter pylori eradication in the healing of atrophic gastritis: a one-year prospective study.
    Arkkila PE, Seppälä K, Färkkilä MA, Veijola L, Sipponen P.
    Scand J Gastroenterol; 2006 Jul; 41(7):782-90. PubMed ID: 16785190
    [Abstract] [Full Text] [Related]

  • 10. Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: a long-term prospective cohort study.
    Toyokawa T, Suwaki K, Miyake Y, Nakatsu M, Ando M.
    J Gastroenterol Hepatol; 2010 Mar; 25(3):544-7. PubMed ID: 19817964
    [Abstract] [Full Text] [Related]

  • 11. [The effects of eradication therapy in patients with chronic atrophic gastritis and seropositivity for anti-HP antibodies and histological negativity for Helicobacter pylori].
    Leri O, Mastropasqua M, Scopelliti G, Grasso E, Losi T, Iadicicco A, Perinelli P.
    Clin Ter; 1999 Mar; 150(5):343-6. PubMed ID: 10687264
    [Abstract] [Full Text] [Related]

  • 12. Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacterpylori antibodies in the management of dyspeptic patients in primary care.
    Germaná B, Di Mario F, Cavallaro LG, Moussa AM, Lecis P, Liatoupolou S, Comparato G, Carloni C, Bertiato G, Battiestel M, Papa N, Aragona G, Cavestro GM, Iori V, Merli R, Bertolini S, Caruana P, Franzé A.
    Dig Liver Dis; 2005 Jul; 37(7):501-8. PubMed ID: 15975537
    [Abstract] [Full Text] [Related]

  • 13. Normalization of pH level and gastric mucosa after eradication of H. pylori in the remnant stomach.
    Kato S, Matsukura N, Matsuda N, Tsuchiya S, Naito Z, Tajiri T.
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S258-61. PubMed ID: 19120908
    [Abstract] [Full Text] [Related]

  • 14. Somatostatin and D cells in patients with gastritis in the course of Helicobacter pylori eradication: a six-month, follow-up study.
    Milutinovic AS, Todorovic V, Milosavljevic T, Micev M, Spuran M, Drndarevic N.
    Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):755-66. PubMed ID: 12811306
    [Abstract] [Full Text] [Related]

  • 15. Normal serum pepsinogen I levels in adults: a population-based study with special reference to Helicobacter pylori infection and parietal cell antibodies.
    Hokkanen S, Kosunen TU, Sarna S, Miettinen A, Salomaa A, Aromaa A, Knekt P, Rautelin HI.
    Scand J Clin Lab Invest; 2005 Jul; 65(4):291-9. PubMed ID: 16076684
    [Abstract] [Full Text] [Related]

  • 16. [Gastric mucosa lesions in gastric ulcer disease. Initial study and 1-year follow-up after Helicobacter pylori eradication].
    Bermejo F, Boixeda D, Gisbert JP, Sanz JM, Defarges V, Alvarez Calatayud G, Martín de Argila C.
    Gastroenterol Hepatol; 2000 Jul; 23(6):269-74. PubMed ID: 15324621
    [Abstract] [Full Text] [Related]

  • 17. [Is measurement of basal levels of serum pepsinogen II useful in proving the eradication of Helicobacter pylori by treatment?].
    Gisbert JP, Boixeda D, Vila T, de Rafael L, Alvarez Baleriola I, Martín de Argila C.
    Med Clin (Barc); 1995 Nov 04; 105(15):561-5. PubMed ID: 7500674
    [Abstract] [Full Text] [Related]

  • 18. Host factors contributing to the discovery of gastric cancer after successful eradication therapy of Helicobacter pylori: preliminary report.
    Takata S, Ito M, Yoshihara M, Tanaka S, Imagawa S, Haruma K, Chayama K.
    J Gastroenterol Hepatol; 2007 Apr 04; 22(4):571-6. PubMed ID: 17376053
    [Abstract] [Full Text] [Related]

  • 19. Helicobacter pylori and impaired gastric secretory functions associated with duodenal ulcer and atrophic gastritis.
    Konturek PC, Konturek SJ, Bobrzyński A, Kwiecień N, Obtułowicz W, Stachura J, Hahn EG, Rembiarz K.
    J Physiol Pharmacol; 1997 Sep 04; 48(3):365-73. PubMed ID: 9376619
    [Abstract] [Full Text] [Related]

  • 20. Usefulness of a serological panel test in the assessment of gastritis in symptomatic children.
    de Angelis GL, Cavallaro LG, Maffini V, Moussa AM, Fornaroli F, Liatopoulou S, Bizzarri B, Merli R, Comparato G, Caruana P, Cavestro GM, Franzé A, Di Mario F.
    Dig Dis; 2007 Sep 04; 25(3):206-13. PubMed ID: 17827941
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.